The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset Parkinson disease (PD). The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily. Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homology to MAP kinase kinase kinases. Using cell fractionation and immunofluorescence microscopy, we show that LRRK2 is localized in the cytoplasm and is associated with cellular membrane structures. The purified LRRK2 protein demonstrates autokinase activity. The disease-associated I2020T mutant shows a significant increase in autophosphorylation of approximately 40% in comparison to wild-type protein in vitro. This suggests that the pathology of PD caused by the I2020T mutation is associated with an increase rather than a loss in LRRK2 kinase activity.

[1]  M. Farrer,et al.  LRRK2 mutations in Parkinson disease , 2005, Neurology.

[2]  A. Mosley,et al.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations , 2005, Neurology.

[3]  M. Farrer,et al.  Pathophysiology, pleotrophy and paradigm shifts: genetic lessons from Parkinson's disease , 2005 .

[4]  Reidun Torp,et al.  Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. , 2005, Human molecular genetics.

[5]  M. Albrecht.  LRRK2 mutations and Parkinsonism , 2005, The Lancet.

[6]  Mathias Toft,et al.  LRRK2 mutations and Parkinsonism , 2005, The Lancet.

[7]  J. Tschopp,et al.  The RIP kinases: crucial integrators of cellular stress. , 2005, Trends in biochemical sciences.

[8]  Yuval Garini,et al.  From micro to nano: recent advances in high-resolution microscopy. , 2005, Current opinion in biotechnology.

[9]  Laurence H Pearl,et al.  Hsp90 and Cdc37 -- a chaperone cancer conspiracy. , 2005, Current opinion in genetics & development.

[10]  Nicholas W Wood,et al.  A common LRRK2 mutation in idiopathic Parkinson's disease , 2005, The Lancet.

[11]  A. Brice.  How much does dardarin contribute to Parkinson's disease? , 2005, The Lancet.

[12]  Y. Chalandon,et al.  Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies. , 2005, Haematologica.

[13]  Nobutaka Hattori,et al.  Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. , 2005, Human molecular genetics.

[14]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[15]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[16]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[17]  C. Mol,et al.  Switching on kinases: oncogenic activation of BRAF and the PDGFR family , 2004, Nature Reviews Cancer.

[18]  Wei Zhang,et al.  Biochemical and structural studies of the interaction of Cdc37 with Hsp90. , 2004, Journal of molecular biology.

[19]  A. Kimchi,et al.  DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation , 2004, Cell Death and Differentiation.

[20]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[21]  Wei Wu,et al.  Hsp90/p50cdc37 Is Required for Mixed-lineage Kinase (MLK) 3 Signaling* , 2004, Journal of Biological Chemistry.

[22]  T. Niki,et al.  DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.

[23]  P. V. van Haastert,et al.  Roc, a Ras/GTPase domain in complex proteins. , 2003, Biochimica et biophysica acta.

[24]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[25]  Tony Pawson,et al.  Regulation and targets of receptor tyrosine kinases. , 2002, European journal of cancer.

[26]  P. Bork,et al.  Functional organization of the yeast proteome by systematic analysis of protein complexes , 2002, Nature.

[27]  B. Kobe,et al.  The leucine-rich repeat as a protein recognition motif. , 2001, Current opinion in structural biology.

[28]  Zhiheng Xu,et al.  The MLK Family Mediates c-Jun N-Terminal Kinase Activation in Neuronal Apoptosis , 2001, Molecular and Cellular Biology.

[29]  E V Koonin,et al.  Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. , 2001, Science.

[30]  N. Lassam,et al.  The Kinase Activation Loop Is the Key to Mixed Lineage Kinase-3 Activation via Both Autophosphorylation and Hematopoetic Progenitor Kinase 1 Phosphorylation* , 2001, The Journal of Biological Chemistry.

[31]  A. Kimchi,et al.  DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer , 2001, Cell Death and Differentiation.

[32]  W. Kolch.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[33]  V. Erfle,et al.  Diminished Rev-Mediated Stimulation of Human Immunodeficiency Virus Type 1 Protein Synthesis Is a Hallmark of Human Astrocytes , 1999, Journal of Virology.

[34]  Temple F. Smith,et al.  The WD repeat: a common architecture for diverse functions. , 1999, Trends in biochemical sciences.

[35]  B. Cochran,et al.  p50cdc37 Acting in Concert with Hsp90 Is Required for Raf-1 Function , 1999, Molecular and Cellular Biology.

[36]  N. Lassam,et al.  Dimerization via Tandem Leucine Zippers Is Essential for the Activation of the Mitogen-activated Protein Kinase Kinase Kinase, MLK-3* , 1998, The Journal of Biological Chemistry.

[37]  M. Farrar,et al.  Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization , 1996, Nature.

[38]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[39]  D. Morrison,et al.  Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro , 1995, Molecular and cellular biology.

[40]  W. Kolch,et al.  Mechanism of inhibition of Raf-1 by protein kinase A , 1994, Molecular and cellular biology.

[41]  D. Morrison,et al.  Identification of the major phosphorylation sites of the Raf-1 kinase. , 1993, The Journal of biological chemistry.

[42]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.

[43]  Y. Fujiki,et al.  Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum , 1982, The Journal of cell biology.